Stay updated on Carfilzomib Pomalidomide Dexamethasone in MM Clinical Trial
Sign up to get notified when there's something new on the Carfilzomib Pomalidomide Dexamethasone in MM Clinical Trial page.

Latest updates to the Carfilzomib Pomalidomide Dexamethasone in MM Clinical Trial page
- ChecktodayChange DetectedRemoved mentions of 'Multiple myeloma' and related topics such as MedlinePlus Genetics from the page.SummaryDifference0.1%

- Check8 days agoChange DetectedRevision label on the page updated from v3.4.1 to v3.4.2; this does not affect study details, eligibility criteria, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check15 days agoChange DetectedAdded 'Multiple myeloma' and related topics such as MedlinePlus Genetics; updated the page revision to v3.4.1. Removed the government funding notice about operating status and the prior revision note v3.4.0.SummaryDifference0.5%

- Check22 days agoChange DetectedCore disease-related content ('Multiple myeloma') and related topics were removed. A general government funding notice was added to the site.SummaryDifference0.5%

- Check29 days agoChange DetectedAdded a glossary display and new metadata fields (Last Update Submitted that Met QC Criteria, Last Update Posted, No FEAR Act Data, Revision: v3.4.0). Removed or renamed some metadata fields (Last Update Submitted that met QC Criteria, Last Update Posted (Estimated), No FEAR Act data, Revision: v3.3.4).SummaryDifference0.2%

- Check36 days agoChange DetectedRevision history updated from v3.3.3 to v3.3.4; no substantive changes to study details or page content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Carfilzomib Pomalidomide Dexamethasone in MM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Carfilzomib Pomalidomide Dexamethasone in MM Clinical Trial page.